Merit Medical Systems, Inc. (MMSI)
| Market Cap | 4.06B |
| Revenue (ttm) | 1.03B |
| Net Income (ttm) | 28.24M |
| Shares Out | 56.06M |
| EPS (ttm) | 0.50 |
| PE Ratio | 144.26 |
| Forward PE | 29.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 171,628 |
| Open | 70.91 |
| Previous Close | 70.85 |
| Day's Range | 69.55 - 72.48 |
| 52-Week Range | 39.45 - 73.85 |
| Beta | 1.25 |
| Analysts | Buy |
| Price Target | 76.22 (+5.7%) |
| Est. Earnings Date | Oct 27, 2021 |
About MMSI
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm managemen...
Financial Performance
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is 76.22, which is an increase of 5.67% from the latest price.
News
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology 1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-mon...
3 Dental Stocks Poised to Perform Well in Second-Half 2021
Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.
Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Merit Medical (MMSI) Expands Drainage Portfolio With New Product
Merit Medical's (MMSI) new commercial product launch can make sample collection simple, safe and efficient.
Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard
Advanced design makes sample collection simple, efficient, and safe Advanced design makes sample collection simple, efficient, and safe
Merit Medical (MMSI) is a Great Momentum Stock: Should You Buy?
Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Merit Medical (MMSI) Hits Fresh High: Is There Still Room to Run?
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Merit Medical's (MMSI) Q2 Earnings Top Estimates, '21 View Up
Merit Medical (MMSI), in the second quarter, benefits from revenue growth across both its segments as well as across all the product categories within its Cardiovascular unit.
Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 40.91% and 11.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Merit Medical Reports Results for Quarter Ended June 30, 2021
* Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-...
Merit Medical (MMSI) Reports Next Week: Wall Street Expects Earnings Growth
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.
Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic...
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on
These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
Investors continue to be optimistic about Merit Medical (MMSI), owing to its potential in the Peripheral Intervention arm and strong international foothold.
Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates
Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q1.
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 40.54% and 7.73%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Merit Medical Systems: Q1 Earnings Insights
Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 36.84% year over year to $0.52, whic...
Merit Medical Reports Results for Quarter Ended March 31, 2021
* Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non...
Merit Medical Systems Earnings Preview
Merit Medical Systems (NASDAQ:MMSI) releases its next round of earnings this Thursday, April 29. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
Earnings Preview: Merit Medical (MMSI) Q1 Earnings Expected to Decline
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch
Let's keep a watch on three lucrative stocks, XRAY, MCK and MMSI, in the dental space that have performed impressively despite the pandemic-led volatility.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Merit Medical Systems, I...
LOS ANGELES--(BUSINESS WIRE)---- $MMSI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potent...
The Law Offices of Frank R. Cruz Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)---- $MMSI #investors--The Law Offices of Frank R. Cruz Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors
INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Merit Medical Systems, Inc.
NEW YORK--(BUSINESS WIRE)---- $MMSI--The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation ...